Salmeterol/fluticasone through breath-actuated inhaler versus pMDI: A randomized, double-blind, 12 weeks study

Journal of Asthma

Volumn 52, Issue 10, 2015, Pages 1065-1072

  Dhar, Raja ^a   Salvi, Sundeep ^b   Rajan, Sujeet ^c   Dalal, Sonia ^d   Tikkiwal, Sharad ^e   Bhagat, Raj ^f   Ahmed, Mohammed Masood ^g   Balki, Akash ^h   Jain, Manish ⁱ   Gogtay, Jaideep ^j  

^a FORTIS HOSPITAL   (India)

^b Chest Research Foundation   (India)

^c Bhatia General Hospital   (India)

^d Ashray Chest Centre   (India)

^e Asthma Bhavan ^*  (India)

^f Dr Bhagat's Allergy Asthma Clinic and Respiratory Care Centre   (India)

^g Revival Chest Clinic   (India)

^h Shree Hospital and Critical Care Centre   (India)

ⁱ Navkar Hospital   (India)

^j CIPLA LTD   (India)

more..

Author keywords

Asthma; Breath actuated inhaler; Preference; Pressurized metered dose inhaler; Salmeterol Fluticasone; SFC BAI; SFC pMDI

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; BRONCHODILATING AGENT; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE;

ADULT; ANEMIA; ARTICLE; ASTHMA; BREATH ACTUATED INHALER; CONTROLLED STUDY; COUGHING; DEVICE SAFETY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PATIENT PREFERENCE; PRESSURIZED METERED DOSE INHALER; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT RESPONSE; LUNG FUNCTION TEST; MIDDLE AGED;

ADULT; ASTHMA; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE DRUG COMBINATION; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; PATIENT PREFERENCE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS;

EID: 84949730366     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2015.1050499     Document Type: Article

References (25)

1. GINA. Global Initiative for Asthma. Available from: http://www.ginasthma.org/local/uploads/files/GINA-Report-March13.pdf2011 [last accessed 6 Dec 2013].
2. Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care 2005;50:1191-1197.
3. Newman SP. Principles of metered-dose inhaler design. Respir Care 2005;50:1177-1188.
4. Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991;46:712-716.
5. O'Callaghan C, Barry P. Spacer devices in the treatment of asthma. BMJ 1997;314:1061-1062.
6. Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet 2004;43:349-360.
7. Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv 2009;6:91-102.
8. Rau JL. Practical problems with aerosol therapy in COPD. Respir Care 2006;51:158-172.
9. Laube BL, Janssens HM, Jongh FHC, Devadason SG, Dhand R, Diot P, Everard ML, et al. What the pulmonary specialist should know about the new inhalation therapies? Eur Respir J 2011;37: 1308-1331.
10. Giraud V, Allaert FA. Improved asthma control with breathactuated pressurized Metered Dose Inhaler (pMDI): the SYSTER survey. Eur Rev Med Pharmacol Sci 2009;13:323-330.
11. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003;16:249-254.
12. Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991;46:712-716.
13. Giraud V, Allaert FA. Improved asthma control with breathactuated pressurized Metered Dose Inhaler (pMDI): the SYSTER survey. Eur Rev Med Pharmacol Sci 2009;13:323-330.
14. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836-844.
15. Woodcock AA, Bagdonas A, Boonsawat W, Gibbs MR, Bousquet J, Bateman ED. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. Prim Care Respir J 2007;16:155-161.
16. Trautmann M, Banik N, Tews JT, Jorres RA, Nowak D. Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting. Eur J Med Res 2007;12:255-263.
17. Guidance for Industry E9 Statistical Principles for Clinical Trials. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073137.pdf [last accessed 5 Mar 2015].
18. Salvi S, Gogtay J, Aggarwal B. Use of breath-actuated inhalers in patients with asthma and COPD-an advance in inhalational therapy: a systematic review. Expert Rev Respir Med 2014;8:89-99.
19. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 2000;94:496-500.
20. Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 2006;100:1139-1151.
21. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007;119:1454-1461.
22. Ryan D, Murphy A, Stallberg B, Baxter N, Heaney LG. "SIMPLES": a structured primary care approach to adults with difficult asthma. Prim Care Respir J 2013;22:365-373.
23. Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med 2010;104:1237-1245.
24. Bronsky EA, Debelic M, Pujet JC, Hahn M. Ease-of-use study of pirbuterol acetate in the Autohaler actuator in three countries: the United States, Germany, and France. J Asthma 1993;30: 439-443.
25. Price DB, Pearce L, Powell SR, Shirley J, Sayers MK. Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract 1999;53:31-36